| Income Statement |
| Total Revenue | 186.67M |
|
| Revenues (USD) | 186.67M |
| Cost of Revenue | 105.81M |
| Gross Profit | 80.86M |
| Operating Expenses | 99.11M |
| Research and Development Expense | 9.53M |
| Selling, General and Administrative Expense | 89.57M |
| Operating Income | -18.24M |
| Interest Expense | 598.00K |
| Income Tax Expense | -472.00K |
| Net Income | -17.11M |
| Net Income Common Stock | -17.11M |
| Net Income Common Stock (USD) | -17.11M |
| Consolidated Income | -17.11M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -16.98M |
| Earning Before Interest & Taxes (USD) | -16.98M |
| Weighted Average Shares | 129.17M |
| Weighted Average Shares Diluted | 129.17M |
| Balance Sheet |
| Cash and Equivalents | 146.14M |
| Cash and Equivalents (USD) | 146.14M |
| Trade and Non-Trade Receivables | 167.42M |
| Current Assets | 373.68M |
| Property, Plant & Equipment Net | 160.36M |
| Total Assets | 1.35B |
| Debt Current | 4.83M |
| Total Debt | 408.53M |
| Current Liabilities | 84.59M |
| Debt Non-Current | 403.70M |
| Total Liabilities | 517.77M |
| Accumulated Retained Earnings (Deficit) | -450.91M |
| Accumulated Other Comprehensive Income | 4.00K |
| Shareholders Equity | 828.76M |
| Shareholders Equity (USD) | 828.76M |
| Assets Non-Current | 972.85M |
| Total Debt (USD) | 408.53M |
| Deferred Revenue | 561.00K |
| Goodwill and Intangible Assets | 802.89M |
| Inventory | 29.84M |
| Liabilities Non-Current | 433.18M |
| Trade and Non-Trade Payables | 25.90M |
| Tax Liabilities | 17.45M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 18.13M |
| Net Cash Flow from Financing | -338.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.47M |
| Capital Expenditure | -5.00M |
| Issuance (Purchase) of Equity Shares | -338.00K |
| Net Cash Flow from Investing | -5.00M |
| Net Cash Flow from Operations | -8.14M |
| Share Based Compensation | 9.64M |